[144] Hims & Hers Health, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice: The filing reports a proposed sale of 2,572 Class A shares of Hims & Hers Health, Inc. through Fidelity Brokerage Services LLC on 08/11/2025, with an aggregate market value of $132,818.08. The company has 217,641,958 shares outstanding. The 2,572 shares were acquired on 06/15/2025 through restricted stock vesting from the issuer and were recorded as compensation.

The filing also lists recent sales by Soleil Boughton over the prior three months: seven transactions between 05/12/2025 and 07/28/2025 totaling 22,207 shares for aggregate gross proceeds of $1,228,936.95. The form includes the standard insider representation regarding material nonpublic information.

Insights

Financial Analyst

TL;DR: Routine Form 144 reporting a small proposed insider sale of 2,572 shares (≈0.00118% of outstanding shares).

The filing documents a proposed sale of 2,572 Class A shares valued at $132,818.08 and shows total outstanding shares of 217,641,958, allowing a simple proportion calculation: 2,572 represents about 0.00118% of outstanding stock. The shares were issued via restricted stock vesting on 06/15/2025 as compensation, indicating the sale arises from recently vested equity rather than an open-market issuance by the company. On face value and given the size relative to total capitalization, this notice is informational and unlikely to materially affect market valuation.

Corporate Governance Expert

TL;DR: Multiple recent insider dispositions are documented; total prior sales equal 22,207 shares for $1,228,936.95.

The schedule of prior sales shows seven transactions by Soleil Boughton between 05/12/2025 and 07/28/2025 totaling 22,207 shares and aggregate gross proceeds of $1,228,936.95. Combined with the new proposed sale of 2,572 shares, the record reflects ongoing insider liquidity activity. The filing includes the standard attestation that the seller is not aware of undisclosed material adverse information. From a governance perspective, the document transparently discloses acquisitions (restricted stock vesting) and subsequent sales, enabling stakeholders to observe insider selling patterns without asserting unprovided motives.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	2572	132818.08	217641958	08/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A	06/15/2025	Restricted Stock Vesting	Issuer			2572	06/15/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	05/12/2025	3235	181160.00
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	05/27/2025	3233	180627.71
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	06/16/2025	5451	309616.80
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	06/17/2025	2572	153677.00
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	06/30/2025	2572	129886.00
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	07/14/2025	2572	122993.04
Soleil Boughton 2269 Chestnut Street #523 San Francisco CA 94123	Class A	07/28/2025	2572	150976.40

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the HIMS Form 144 report?

The notice reports a proposed sale of 2,572 Class A shares via Fidelity Brokerage Services LLC on 08/11/2025 with an aggregate market value of $132,818.08.

Who appears as a seller in recent transactions listed in the filing?

The filing lists past sales by Soleil Boughton; the current filer name is not explicitly provided elsewhere in the document.

How and when were the 2,572 shares acquired?

The shares were acquired on 06/15/2025 through restricted stock vesting from the issuer and were recorded as compensation.

How many shares does HIMS have outstanding and what percent does 2,572 represent?

The filing shows 217,641,958 shares outstanding; 2,572 shares equal approximately 0.00118% of that total.

What were total insider sales in the past three months listed?

Seven transactions by Soleil Boughton between 05/12/2025 and 07/28/2025 totaled 22,207 shares for aggregate gross proceeds of $1,228,936.95.

Which broker is named for the proposed sale?

The proposed sale is listed through Fidelity Brokerage Services LLC, address shown in the filing.